Texray AB | Gothenburg, Sweden | March 31, 2022 |

EuroPCR, the annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology, has invited Texray to present in Paris May 19th, 2022.


PCR Innovators Day is a programme that enables clinicians, medical experts, innovators, MedTech executives and investors in the cardiovascular field to meet, exchange ideas and network on the most transformative technology projects worldwide.

“We are thrilled to have been invited to present our patented textile innovations at EuroPCR in May. This contributes to our mission to enhancing the safety for healthcare professionals by creating solutions that reduce radiation as much as reasonably achievable”, says Petra Apell founder and CEO at Texray.

EuroPCR 2022 will be the first in-person reunion for the interventional cardiovascular community in two years. More than 10,000 medical professionals and researchers will meet in Palais Des Congres de Paris between 17 – 20 May 2022 to discover the latest advancements in cardiovascular medicine.

“EuroPCR in Paris is definitely one of the key meetings for many of our clinical and industrial partners and presenting our textile innovations to this prestigious audience is of course a fantastic opportunity”, says Jeffrey Jump, Chairman of the Board at Texray.